YY/T 1261-2015 Active Industry standards-Medicine

YY/T 1261-2015 Detection kit for analysis of HER2 gene abnormalities(fluorescent in situ hybridization )

YY/T 1261-2015 Detection kit for analysis of HER2 gene abnormalities(fluorescent in situ hybridization )

Publish Date: 2015-03-02 Implement Date: 2016-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Basic Information

Standard Code: YY/T 1261-2015
Standard Type: Industry standards
Standard Status: Active
is_force_gb: no
CCS Name: Medical laboratory equipment
ICS Name: Laboratory medicine
Publish Date: 2015-03-02
Implement Date: 2016-01-01
Pages: 7 pages

Scope

This standard specifies the definition, requirements, test methods, marking, labeling, user's manual, packaging, transportation, and storage of HER2 gene detection kits (fluorescence in situ hybridization method).
This standard applies to kits composed of HER2 gene loci and fluorescence in situ hybridization probes and counterstaining agents on chromosome 17. By detecting abnormalities in the HER2 gene loci on samples (usually breast cancer tissue sections), the kits assist in diagnosing tumors related to the HER2 gene (such as breast cancer) and guide clinical medication during treatment.

Development Information

Word Count: 12 Thousand words Pages: 7 pages

Referenced Standards

Related Standards

Contact Us